Futura Medical (FRA:GYX) ROE % Adjusted to Book Value : 2.23% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Futura Medical ROE % Adjusted to Book Value?

Futura Medical's ROE % for the quarter that ended in Jun. 2024 was 30.38%. Futura Medical's PB Ratio for the quarter that ended in Jun. 2024 was 13.61. Futura Medical's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 2.23%.

Futura Medical ROE % Adjusted to Book Value Historical Data

The historical data trend for Futura Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical ROE % Adjusted to Book Value Chart

Futura Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-15.75

-8.37

-2.80

-9.91

Futura Medical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-5.42	-3.86	-2.44	-10.86	2.23

Competitive Comparison of Futura Medical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Futura Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Futura Medical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Futura Medical's ROE % Adjusted to Book Value falls into.

Futura Medical ROE % Adjusted to Book Value Calculation

Futura Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-128.31%	/	12.95
	=	-9.91%

Futura Medical's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	30.38%	/	13.61
	=	2.23%

Futura Medical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Futura Medical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Futura Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (FRA:GYX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

FAMDF:USA FUM:UK

Address

40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG

Website

https://www.futuramedical.com

Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.

Futura Medical Headlines

No Headlines